Screening of New Antibiotics Inhibiting Bacterial Enoyl-Acyl Carrier Protein Reductase (Fabl) |
곽진환 (한동대학교 생물식품공학부) |
1 |
Characterization of Pseudomonas aeruginosa enoyl-acyl carrier protein reductase(FabI): a target for the antimicrobial tricolosan and its role in acylated homoserine lactone synthesis
/
|
2 |
Mechanism of trichlosan inhjibition of bacterial fatty acid synthesis
/
DOI ScienceOn |
3 |
Inhibiton of the Staphylococcus auteus NADPH-dependent enoyl-acyl carrier protein reductase by trclosan and hexachlorophene
/
DOI ScienceOn |
4 |
Innovative approaches to nevel antibacterial drug discovery.
/
|
5 |
Harnessing the power of the genome in the search for new antibiotics
/
DOI |
6 |
Inhibition of a Mycobacterium tiberculosis β-ketoacyl ACP syntherase by Isoniazid
/
DOI |
7 |
Recombinant proteins attached to a Ni-NTA Column : Use in affinity purification of antibodies
/
|
8 |
Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan
/
DOI |
9 |
Genomics and antimicrobial drug discovery
/
|
10 |
Metal Chelate affinity chromatography, a new approach to protein fractionation
/
DOI ScienceOn |
11 |
Enoyl-acyl carrier protein reductase(fabI) plays a determinant role in completirg cycles of fatty acid elongation in Escherichir coli
/
DOI ScienceOn |
12 |
Broad spectrum antimicrobial biocides target the FabI component of fatty acid synthesis
/
DOI |